Fully Implanted Device Approved for Trials
Fully Implanted Envoy Acclaim Cochlear Device FDA Approved for Trials Envoy Medical, Inc. (NASDAQ: COCH), a leader in hearing health innovation, announced that the FDA has approved its Investigational Device Exemption (IDE) application for a pivotal study of the Acclaim® Fully Implanted Cochlear Implant. This device, unlike traditional cochlear implants, uses an implanted sensor designed…
New CPT Codes Approved for Envoy Medical’s Esteem® Device
American Medical Association Approves New CPT Codes for Envoy Medical’s Esteem® Device On October 22, 2024, Envoy Medical, Inc. (NASDAQ: COCH), a leader in fully implanted hearing devices, announced that the American Medical Association (AMA) has approved five new Category III Current Procedural Terminology (CPT) codes for totally implantable active middle ear implants (AMEI), including…
Dr. Goldstein Speaks at American Academy of Audiology Conference
Dr. Mary Rose Goldstein, lead audiologist at Center for Neurosciences, was recently invited to speak at the American Academy of Audiology 2024 conference in Atlanta, GA, alongside Dr. Terry Zwolan. They discussed the application of aided speech testing, akin to the Minimum Speech Test Battery Version 3 (MSTB-3), for validating hearing aid fittings. Dr. Goldstein…
Empowering Children with Hearing Loss
Optimizing pediatric aided hearing involves a comprehensive approach that encompasses various strategies to maximize the effectiveness of hearing aids, cochlear implants or bone-anchored hearing implants (BAHI) for children who are d/Deaf or hard of hearing. These strategies aim to provide children with the best possible access to sound, facilitate auditory development and support language and…
CNS Audiologist Speaks at Cleveland Clinic
Dr. Mary Rose Goldstein, the lead audiologist at the Center for Neurosciences, was invited as a guest lecturer at Cleveland Clinic’s Departmental Audiology Meeting, regarding her research and clinical protocols on aided speech recognition testing for hearing aid fitting validation and the importance of establishing minimum standards of care for hearing aid fit-validation. In her…
Dr. Jacob named Investigator on NSF Grant for Cochlear Implant Innovation
Dr. Abraham Jacob Named Co-Principal Investigator on National Science Foundation (NSF) Convergence Accelerator Research Grant To Spur Innovations in Cochlear Implant Technology. This convergence research will develop medical instruments that sense their own shape changes during complex surgeries to provide real-time tactile feedback to surgeons. The team is using a bio-inspired approach, synthesizing data from…
Dr. Goldstein on The Hearing Journal Podcast
Dr. Mary Rose Goldstein, lead audiologist at Center for Neurosciences, was invited by the Hearing Journal podcast to speak about her aided speech testing research and how it relates to the recently revised minimum speech test battery developed for cochlear implants. The joint interview with Dr. Terry Zwolan highlights the importance of utilizes consistent speech…
CNS Audiology Attends NYU Conference
In a significant stride towards advancing cochlear implant knowledge, the audiologists from Center for Neurosciences recently attended the NYU Langone Health conference: Maximizing Performance in Cochlear Implant Recipients last weekend. This gathering of top-tier professionals and experts has proven to be a cornerstone in the evolution of cochlear implant technology, programming, and patient care. The…
Traumatic Brain Injury and the Ear
Patients with TBI should be evaluated by audiologists for hearing and inner ear balance dysfunction Mary Rose Goldstein, Au.D. Traumatic Brain Injury (TBI) affects approximately 55 million people world-wide annually and is associated with a wide array of physical, cognitive, emotional, or sensory symptoms. TBI can cause symptoms related to the inner ear. The following…
Hearing Aids Decrease Cognitive Dysfunction: Early Study Results
In clinical practice, the transformative effects of treating hearing loss via various interventions like stapes surgery, cochlear implantation, or hearing aids have been self-evident, significantly impacting patients’ social interactions, exhaustion levels, and connectivity with loved ones. Recent studies indicate that untreated hearing loss in older adults is linked to social isolation, frequent falls, higher healthcare…
E&H Team Invited to Present at American Cochlear Implant Alliance
The American Cochlear Implant Alliance (ACIA) 2023 Conference served as a catalyst for innovation and collaboration in the field of implantable hearing devices. Held in Dallas, Texas, the meeting brought together leading surgeons, audiologists, researchers, and allied healthcare professionals to discuss advancements, share knowledge, address critical issues, and present groundbreaking research in the realm of hearing restoration.Dr. Abraham…
Medicare Expands Cochlear Implant Candidacy Guidelines
In the past, Medicare strictly limited the eligibility criteria for cochlear implants, primarily reserving this resource for individuals with profound hearing loss in both ears. Over the years, Medicare has incrementally changed their guidance, with a primary focus on expanding indications and improving access for patients. These changes have played a crucial role in enhancing the…